1733 On Other Exchanges
Symbol
Exchange
1733 is not on other exchanges.

apex biotechnology corp (1733) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for APEX BIOTECHNOLOGY CORP (1733)

Related News

No related news articles were found.

apex biotechnology corp (1733) Related Businessweek News

No Related Businessweek News Found

apex biotechnology corp (1733) Details

Apex Biotechnology Corp. engages in the research, development, manufacture, and sale of medical devices by using biosensor technology worldwide. It offers blood glucose, uric acid, lactate, hemoglobin, cholesterol, and ketone monitoring systems, as well as hemoglobin screening systems. The company also provides pesticide residues check systems; and care management and tele-health services. Apex Biotechnology Corp. was founded in 1997 and is headquartered in Hsinchu, Taiwan.

Founded in 1997

apex biotechnology corp (1733) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

apex biotechnology corp
Apex Biotechnology Corp., Annual General Meeting, Jun 02, 2017

Apex Biotechnology Corp., Annual General Meeting, Jun 02, 2017.

Apex Biotechnology Corporation Proposes Amendments to Articles of Incorporation

Apex Biotechnology Corporation will propose amendments to the Articles of Incorporation at the Annual Shareholders' Meeting to be held on May 31, 2016.

Apex Biotechnology Corp., Annual General Meeting, May 31, 2016

Apex Biotechnology Corp., Annual General Meeting, May 31, 2016, at 09:00 Taipei Standard Time. Location: No.7, Li-Hsin 5th Rd. Hsinchu Science Park Hsinchu Taiwan Agenda: To consider discussion of amendments to the Articles of Incorporation; to consider report the business of 2015; to consider compensation committee's review report; to report the first and second domestic unsecured convertible bonds transferring; to report the distribution of 2015 profits to the directors and the employees; to consider adoption of the 2015 business report and financial statements; and to consider adoption of the proposal for distribution of 2015 profits.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

1733 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 1733.
View Industry Companies
 

Industry Analysis

1733

Industry Average

Valuation 1733 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.0x
Price/Book 2.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact APEX BIOTECHNOLOGY CORP, please visit www.apexbio.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.